Clinical Trials Logo

Malignant Neoplasm clinical trials

View clinical trials related to Malignant Neoplasm.

Filter by:

NCT ID: NCT04410302 Recruiting - Malignant Neoplasm Clinical Trials

Patient-Derived Xenografts to Reduce Cancer Health Disparities

Start date: November 12, 2019
Phase:
Study type: Observational

This trial establishes patient-derived cancer xenografts in addressing cancer health and treatment disparities that disproportionately affect racial/ethnic minorities. Understanding the genetic and response differences among racial/ethnic minorities may help researchers enhance the precision of therapeutic treatments.

NCT ID: NCT04292769 Recruiting - Malignant Neoplasm Clinical Trials

Clinical Study of DC-CIK Cells as a Post-remission Treatment for Malignant Tumors

Start date: January 21, 2020
Phase: Phase 3
Study type: Interventional

1. Screening stage 2. Evaluation of disease 3. Grouping of patients 4. Infusion of cells 5. Surveillance of adverse effect

NCT ID: NCT04185935 Recruiting - Malignant Neoplasm Clinical Trials

Molecular Genetics Studies of Cancer Patients and Their Relatives

Start date: April 18, 1997
Phase:
Study type: Observational

This trial studies the genetic and behavioral factors that may contribute to the development of specific cancers and how these factors may affect the outcome of the disease in patients with a history of cancer and their relatives.

NCT ID: NCT04160390 Recruiting - Malignant Neoplasm Clinical Trials

Blood Samples to Identify Biomarkers in Patients Treated With Cyclophosphamide After Donor Stem Cell Transplant

Start date: November 13, 2018
Phase:
Study type: Observational

This trial uses blood samples to understand how patients' bodies process and respond to a drug called cyclophosphamide given after a donor stem cell transplant. Identifying biomarkers (molecules that can indicate normal or abnormal processes) may help researchers develop a blood test that can be used to predict how well patients will process and respond to cyclophosphamide.

NCT ID: NCT03971266 Recruiting - Malignant Neoplasm Clinical Trials

Movement and Fitness Trackers in Determining Performance Status

Start date: March 27, 2019
Phase: N/A
Study type: Interventional

This trial studies the use of movement and fitness trackers in determining performance status of patients with cancer who are taking part in early phase clinical. Movement and fitness trackers record movement and a number of different metrics such as steps, heart rate, and calories burned. The use of movement and fitness trackers can provide a more objective and precise estimate of patient performance status and help identify those most at risk for adverse events and hospitalization.

NCT ID: NCT03915717 Recruiting - Malignant Neoplasm Clinical Trials

Observational Study of Outcomes After EchoMark and EchoSure-based Free Flap Monitoring

Start date: September 19, 2019
Phase:
Study type: Observational

The purpose of this study is to evaluate the performance of the EchoMark and EchoSure as an ultrasound-based method of monitoring the viability of free flaps and patency of at-risk vessels.

NCT ID: NCT03890575 Recruiting - Malignant Neoplasm Clinical Trials

Airway Segmented Stent Modified With 3D Printing for Malignant Stricture Involving Carina and Distal Bronchi

Start date: April 1, 2017
Phase: N/A
Study type: Interventional

In this study, we used the covered metallic segmented airway stent to treat malignant strictures involving carina and bronchi distal to carina and aimed to determine the feasibility, efficacy and safety of this technique.

NCT ID: NCT03741673 Recruiting - Malignant Neoplasm Clinical Trials

Pre-operative SRS or Post-operative SRS in Treating Cancer Patients With Brain Metastases

Start date: November 8, 2018
Phase: Phase 3
Study type: Interventional

This phase III trial studies stereotactic radiosurgery (SRS) before surgery to see how well it works compared with SRS after surgery in treating patients with cancer that has spread to the brain (brain metastases). SRS is the delivery of focused, high-dose radiation given in a single session to the tumors, with a minimal dose given to uninvolved areas of the brain.

NCT ID: NCT03696030 Recruiting - Breast Cancer Clinical Trials

HER2-CAR T Cells in Treating Patients With Recurrent Brain or Leptomeningeal Metastases

Start date: August 31, 2018
Phase: Phase 1
Study type: Interventional

This phase I trial studies the side effects and best dose of HER2-CAR T cells in treating patients with cancer that has spread to the brain or leptomeninges and has come back (recurrent). HER2-CAR T cells delivered into the ventricles of the brain may recognize and kill tumor cells.

NCT ID: NCT03568292 Recruiting - Malignant Neoplasm Clinical Trials

Virtual Reality in Reducing Pain and Anxiety in Cancer Participants Undergoing Painful Procedures

Start date: March 1, 2022
Phase: N/A
Study type: Interventional

This trial studies how well virtual reality (VR) works in reducing pain and anxiety in cancer participants undergoing bone marrow biopsy or lumbar puncture. Virtual reality may impact pain and anxiety during and after the procedure.